Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N , N-Dimethyltryptamine , and the Impact of CYP2D6 Status .
O O O B-MAT O O O B-MAT O B-MAT I-MAT I-MAT O O O O O O O O